| Which
devices are available: Advantages and disadvantages |
 |
| C Gardiner,
University
College
Hospital,
London, UK. |
|
| |
|
| How
to get reliable results |
 |
| E Murray,
Department of General Practice,
University of Birmingham,
UK |
|
| |
|
|
Laboratory and POC INR results: Which to believe? |
 |
| D Kitchen,
UK NEQAS Blood coagulation,
UK |
|
| |
|
|
Management of over anticoagulated patients |
 |
| M Makris,
Sheffield Haemostasis and Thrombosis, Centre,
Sheffield,
UK |
|
| |
|
|
Debate: Oral anticoagulant therapy is best supervised in Primary
Care |
|
| For:
D Fitzmaurice, University of Birmingham, UK |
 |
| Against:
S Machin, University
College
Medical
School, London
UK |
 |
| |
|
|
Anticoagulation in atrial fibrillation |
 |
| G Lowe,
Division of Cardiovascular and Medical Sciences,
University of Glasgow, UK |
|
| |
|
|
Duration of anticoagulant therapy following first VTE |
 |
| C Tait,
Glasgow
Royal Infirmary, Glasgow, UK |
|
| |
|
|
Bridging anticoagulation for invasive procedures |
 |
| R Maclean,
Sheffield Teaching Hospitals NHS Foundation Trust
UK |
|
| |
|
| New
anticoagulant drugs |
 |
| Henry Watson, Aberdeen Royal Infirmary, Scotland, UK |
|